January 2006 - June 2006

Assigned Products;

1. Mixtard (Premix human insulin in vials and dispossable pens)
2. Insulatard (NPH insulin in vials and dispossable pens)
3. Actrapid (Regular human insulin in vials and dispossable pens)
4. NovoNorm (Repaglinide - short acting insulin secretagogue)

Key Achievements;

# Developed new business spots (immediately) after losing business due to Denmark caricature issue raised in Feb 2006
# Highest seller in QII-2006
# Got 1st position in situational detailing contest
# Promoted as Product Specialist for upcoming strategic product NovoSeven